✨ Free AI Report
Enanta Pharmaceuticals, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Enanta Pharmaceuticals, Inc.
Research Preview

Enanta Pharmaceuticals, Inc.: Business Overview, Financials & Competitive Analysis

Enanta Pharmaceuticals is a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases. The company discovered glecaprevir, a protease inhibitor use...

Analyst-debate audio for Enanta Pharmaceuticals, Inc.

AskCyborg analysts argue the bull and bear cases for Enanta Pharmaceuticals, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Enanta Pharmaceuticals, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
7/ 10Strong

Cyborg Score thesis

Well-capitalized clinical-stage biotech with differentiated small molecule RSV and immunology programs, supported by sustainable...

Read the full analyst-debate transcript →
Industry Biopharmaceuticals - Antiviral and Immunology
2 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: June 22, 2026
AI-Verified Research
30+ Page Report

Get the Latest Enanta Pharmaceuticals, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Enanta Pharmaceuticals, Inc. Overview

Pro stress-test →

Enanta Pharmaceuticals is a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases. The company discovered glecaprevir, a protease inhibitor used in one of the leading hepatitis C treatment regimens (MAVYRET), and receives ongoing royalties from AbbVie that fund operations.

Strategic Profile

Pro stress-test →

Enanta's virology pipeline includes the leading portfolio in development for RSV treatment, consisting of zelicapavir and EDP-323, both of which received Fast Track designation from the FDA. The company is building a leading immunology portfolio focused on type 2 immune driven diseases through KIT, STAT6 and MRGPRX2 inhibitors, with strong cash position and runway into fiscal 2029.

Competitive Landscape

Pro stress-test →

Enanta's STAT6 inhibitor EPS-3903 targets the atopic dermatitis market currently dominated by dupilumab (AbbVie). RSV antivirals compete against other small molecule programs in development. The company leverages proven expertise in small molecule drug discovery to address type 2 immune driven diseases with oral treatment options.

Industry Context

Enanta Pharmaceuticals, Inc. operates in Biopharmaceuticals - Antiviral and Immunology.

Key facts

Headquarters: Watertown, Massachusetts, US · Revenue: $18.6M (Q1 FY2026)

What the analysts stress-tested

The top findings that survived the multi-agent debate for Enanta Pharmaceuticals, Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Enanta Pharmaceuticals, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

DupilumabBiologic for atopic dermatitis and allergic diseases; oral STAT6 inhibitors aim to offer convenient alternative→RSV antivirals (multiple programs)Competing small molecule and biologic RSV treatments in clinical development→

Compare Enanta Pharmaceuticals, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Enanta Pharmaceuticals, Inc. operates in Biopharmaceuticals - Antiviral and Immunology. See how the rest of the sector scores on the Cyborg framework.

Browse Biopharmaceuticals - Antiviral and Immunology research →
NEW · MCP server

Ask your AI assistant about Enanta Pharmaceuticals, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Enanta Pharmaceuticals, Inc. and its top competitor on Cyborg Score”
“What did Enanta Pharmaceuticals, Inc. do this quarter?”
“Is Enanta Pharmaceuticals, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Enanta Pharmaceuticals, Inc. do?+
Enanta Pharmaceuticals is a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases. The company discovered glecaprevir, a protease inhibitor use...
What is Enanta Pharmaceuticals, Inc.'s Cyborg Score?+
Enanta Pharmaceuticals, Inc. has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Enanta Pharmaceuticals, Inc.'s main competitors?+
Named competitors include Dupilumab, RSV antivirals (multiple programs). The full competitive landscape is in the AskCyborg report.
How can I get the full Enanta Pharmaceuticals, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Enanta Pharmaceuticals, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Enanta Pharmaceuticals, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

Other strong performers across the analyst-debate framework. Click any to see their research report.

9Dave Inc.9nVent Electric plc9Elbit Systems Ltd.9Vertiv Holdings Co9Barrick Mining Corporation9GE Vernova Inc.9Applied Materials, Inc.9Eli Lilly and Company9Microsoft Corporation8Dätwyler Holding AG8Cingulate Inc.8Tristel plc8cBrain8Electrovaya Inc.8Kits Eyecare Ltd.8Sukoon Insurance8Lumax Industries Limited8Tanla Platforms Limited